A round burgundy crest emblem with simple gold ring detailing, plain and formal in style
A wide horizontal photograph of mountain scenery near Banff with pale turquoise sky, dark evergreen slopes, and a soft muted mood
A round burgundy crest emblem mirroring the first, with plain gold ring detailing and a formal quiet mood

Annual Scientific Meeting of the Canadian Organization of Medical Physicists — July 9–12, 2014, The Banff Centre, Banff, Alberta, Canada

Linac Quality Assurance From Daily Checks To Annual Confidence

A medical linear accelerator can deliver highly conformal treatment only when its mechanical, dosimetric and imaging systems remain aligned. Quality assurance (QA) therefore works as a chain: daily checks identify immediate changes, monthly measurements reveal trends, and annual testing confirms that the machine still meets the tolerance framework used by the department.

The 2014 Annual Scientific Meeting of the Canadian Organization of Medical Physicists in Banff placed scientific exchange, clinical practice and professional standards at the centre of medical physics. That setting remains relevant to Australian departments, where a small physics team may support several treatment machines, deal with vendor servicing across long distances and maintain safe operation within a busy public or private oncology service.

Why A Layered QA Programme Matters

A daily linac check is a safety screen rather than a complete performance assessment. Typical checks include output constancy, laser alignment, optical and radiation field coincidence, imaging functionality, door interlocks, audiovisual systems and basic couch movement. The measurements should be quick enough to complete before the first patient, yet structured enough to expose a meaningful change.

Consider a case in which the morning output result is within tolerance, but the kV imaging panel fails to acquire an image and the treatment-room laser appears displaced. The machine may still produce radiation, but it is not ready for clinical use. A simple pass-or-fail workflow should stop treatment, identify the affected subsystem and escalate the issue to the responsible physicist or service engineer.

The value of daily QA increases when results are trended rather than stored as isolated numbers. A gradual shift in output, imaging dose, symmetry or field size can signal a developing fault before it becomes an incident. Reviewing charts during the weekly physics meeting is especially useful when the same accelerator supports stereotactic treatments, total body irradiation or high-volume conventional therapy.

A Daily And Weekly Case Study

Imagine a dual-energy linac used in a metropolitan Australian cancer centre. The morning constancy check shows a small but repeatable decline in the 10 MV reading over four days, while the 6 MV result remains stable. The value has not crossed the local action level, so treatment could technically continue, but the trend warrants investigation rather than passive observation.

The physicist repeats the measurement with a second setup, checks chamber positioning and compares the result with the independent daily device. If the decline is confirmed, the team can inspect recent service records, review beam steering information and arrange vendor support. This response illustrates an important principle: tolerance limits support decisions, but clinical judgement interprets the pattern.

Weekly QA can add checks that are impractical every morning, such as a broader output review, electron applicator assessment, wedge or accessory verification, and more detailed imaging or mechanical tests. In Australia, where a regional service may have one physicist covering leave, travel and after-hours duties, a clearly assigned backup process prevents a missed weekly test from becoming an invisible gap.

Monthly And Annual Verification

Monthly QA provides a deeper review of the treatment unit. Common elements include photon and electron output, beam quality, profile or symmetry, field-size indicators, light-radiation coincidence, MLC positioning, jaw and collimator movement, couch rotation, imaging geometry and accessory identification. The exact schedule should reflect the machine model, clinical techniques and the department’s risk assessment.

An annual programme brings together measurements that require more time, specialist equipment or access to the treatment system. Absolute dose calibration, beam-quality verification, output factors, transmission, mechanical isocentre, gantry and couch accuracy, MLC performance, imaging dose and end-to-end testing may all be included. For stereotactic workflows, small-field dosimetry, image guidance and patient-specific localisation deserve particular attention.

Annual testing should also examine whether the QA programme itself remains fit for purpose. A new software release, upgraded detector, changed reference chamber or altered treatment technique can invalidate old assumptions. The department should map each test to a recognised protocol, such as AAPM or IAEA guidance, and document why local tolerances and action levels are appropriate.

Records, Escalation And Professional Judgement

Good QA records make the machine’s history visible. Each entry should identify the accelerator, test device, operator, date, conditions, measured value, tolerance, action taken and release decision. Electronic systems can automate trend plots and reminders, but a spreadsheet or controlled paper form can also work when version control and review responsibilities are explicit.

A failed result needs a defined escalation pathway. The operator should know when to repeat a measurement, when to remove the machine from clinical service, who can authorise a return to treatment and how to assess patients treated since the last acceptable result. These decisions should be supported by local policies, incident learning and a clear distinction between a warning level and a clinical stop level.

The professional culture around QA matters as much as the equipment. The president’s address from the Banff meeting reflects the value of shared responsibility and communication within the medical physics community. In practice, that means physicists, radiation therapists, engineers and oncologists should be able to report an abnormal observation without delaying escalation through uncertainty about ownership.

Applying The Lessons In Australian Departments

Australian services operate across very different conditions. A large Sydney or Melbourne centre may have several accelerators, dedicated QA staff and automated data collection, while a regional Queensland, Western Australia or Tasmania service may depend on a smaller team and a travelling engineer. A practical programme must be robust in both settings, including during school-holiday leave periods and the long distances between rural sites.

The regulatory environment also requires careful local alignment. Departments should consider relevant state or territory radiation requirements, ACPSEM professional guidance, ARPANSA expectations and the recommendations attached to their equipment and clinical techniques. A public hospital may use central procurement and formal service-level agreements, whereas a private provider may compare vendor contracts, independent testing and machine uptime more directly.

Australian treatment rooms also face operational pressures familiar to local staff: a full morning list, add-on palliative cases, urgent imaging and patients travelling from places such as Dubbo, Cairns or Kalgoorlie. Saying that a machine is “right for treatment” must therefore mean more than a green dashboard. It should reflect current measurement evidence, reliable image guidance and a documented clinical release.

The exchange of practical methods is one reason conference material remains useful after an event has ended. Reviewing poster presentation highlights can prompt Australian teams to compare local approaches to automation, detector choice, trend analysis and risk-based testing without assuming that every department has identical resources.

Practical Recommendations For Linac QA

A sustainable programme should be easy to follow on an ordinary Tuesday morning and strong enough to support an audit, an investigation or a difficult release decision. The following actions help connect daily observations with annual assurance:

  • Define daily, weekly, monthly and annual tests by machine, technique and responsible role.
  • Use independent checks for output and investigate trends before they exceed formal tolerances.
  • Record action levels, stop levels, repeat-measurement rules and return-to-service authority.
  • Review QA data after software upgrades, major repairs, detector changes and new treatment techniques.
  • Include imaging, MLC, couch, interlocks and end-to-end performance alongside dose measurements.
  • Schedule contingency cover for leave, public holidays, vendor delays and regional travel.

A case-based review can turn these actions into routine behaviour. Select a real or simulated event, follow the measurement trail from the first abnormal result, and ask whether the available records support the final clinical decision. Repeating this exercise across photon, electron, image-guided and stereotactic workflows exposes weaknesses that a checklist alone may leave hidden.

Bring the discussion into the next departmental QA meeting, compare your current tolerances with the equipment and techniques in use, and strengthen the pathway from first warning to safe clinical release. A well-designed programme gives the treatment team timely evidence that every patient receives the intended dose, geometry and image guidance.